Yu-lin Li
Key Laboratory Of Pathobiology, 126 Xin Min Ave
Changchun, 130021, China
Changchun, 130021, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Biomarkers for immune checkpoint therapy targeting programmed death 1 and programmed death ligand 1.
Biomarkers for immune checkpoint therapy targeting programmed death 1 and programmed death ligand 1.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: May 19, 2020
Upregulation of programmed death ligand 1 by liver kinase B1 and its implication in programmed death 1 blockade therapy in non-small cell lung cancer.
Journal: Life sciences
Published: April 24, 2020
Enhanced O-linked Glcnacylation in Crohn's disease promotes intestinal inflammation.
Journal: EBioMedicine
Published: January 15, 2020
AMP-activated protein kinase protects against necroptosis via regulation of Keap1-PGAM5 complex.
Journal: International journal of cardiology
Published: September 11, 2017
PARP-1 inhibitors sensitize HNSCC cells to APR-246 by inactivation of thioredoxin reductase 1 (TrxR1) and promotion of ROS accumulation.
Journal: Oncotarget
Published: May 11, 2017
O-linked GlcNAcylation elevated by HPV E6 mediates viral oncogenesis.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: August 03, 2016
LKB1 is a DNA damage response protein that regulates cellular sensitivity to PARP inhibitors.
Journal: Oncotarget
Published: June 29, 2016
Induction of BCL2-Interacting Killer, BIK, is Mediated for Anti-Cancer Activity of Curcumin in Human Head and Neck Squamous Cell Carcinoma Cells.
Journal: Journal of Cancer
Published: November 26, 2014
Knockdown of hTERT by siRNA inhibits cervical cancer cell growth in vitro and in vivo.
Journal: International journal of oncology
Published: March 20, 2014
Lidamycin regulates p53 expression by repressing Oct4 transcription.
Journal: Biochemical and biophysical research communications
Published: February 25, 2014
Berberine protects against palmitate-induced endothelial dysfunction: involvements of upregulation of AMPK and eNOS and downregulation of NOX4.
Journal: Mediators of inflammation
Published: July 23, 2013
Last Updated: 09/26/2026